Familial Alzheimer's disease associated with heterozygous NPC1 mutation

被引:0
|
作者
Lopergolo, Diego [1 ,2 ]
Bianchi, Silvia [1 ,2 ]
Gallus, Gian Nicola [1 ,2 ]
Locci, Sara [1 ,2 ]
Pucci, Barbara [1 ,3 ]
Leoni, Valerio [4 ]
Gasparini, Daniele [1 ,2 ]
Tardelli, Elisa [5 ]
Chincarini, Andrea [6 ]
Sestini, Stelvio [5 ]
Santorelli, Filippo Maria [7 ]
Zetterberg, Henrik [8 ,9 ,10 ,11 ,12 ]
De Stefano, Nicola [1 ,2 ]
Mignarri, Andrea [1 ,2 ,13 ]
机构
[1] Univ Siena, Dept Med Surg & Neurosci, Siena, Italy
[2] Azienda Osped Univ Senese, UOC Neurol & Malattie Neurometab, Siena, Italy
[3] Azienda Osped Univ Senese, UOC Neurol & Neurofisiol Clin, Siena, Italy
[4] Univ Milano Bicocca, Hosp Desio, ASST Brianza, Lab Clin Chem,Sch Med & Surg, Milan, Italy
[5] Azienda USL Toscana Ctr, Dept Diagnost Imaging, Unit Nucl Med, PO S Stefano, Prato, Italy
[6] Natl Inst Nucl Phys INFN, Genoa, Italy
[7] IRCCS Stella Maris Fdn, Mol Med Neurodegenerat & Neuromuscular Dis Unit, Calambrone, Italy
[8] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden
[9] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden
[10] UCL, UK Dementia Res Inst, London, England
[11] UCL, Dept Neurodegenerat Dis, Inst Neurol, London, England
[12] Hong Kong Ctr Neurodegenerat Dis, Hong Kong, Peoples R China
[13] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy
基金
欧洲研究理事会; 欧盟地平线“2020”;
关键词
brain diseases; metabolic; central nervous system diseases; neurodegenerative diseases; dementia; NIEMANN-PICK-DISEASE; RAPID DIAGNOSIS; 7-KETOCHOLESTEROL; PLASMA; METABOLISM; DISORDERS; RISK;
D O I
10.1136/jmg-2023-109219
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction NPC1 mutations are responsible for Niemann-Pick disease type C (NPC), a rare autosomal recessive neurodegenerative disease. Patients harbouring heterozygous NPC1 mutations may rarely show parkinsonism or dementia. Here, we describe for the first time a large family with an apparently autosomal dominant late-onset Alzheimer's disease (AD) harbouring a novel heterozygous NPC1 mutation.Methods All the five living siblings belonging to the family were evaluated. We performed clinical evaluation, neuropsychological tests, assessment of cerebrospinal fluid markers of amyloid deposition, tau pathology and neurodegeneration (ATN), structural neuroimaging and brain amyloid-positron emission tomography. Oxysterol serum levels were also tested. A wide next-generation sequencing panel of genes associated with neurodegenerative diseases and a whole exome sequencing analysis were performed.Results We detected the novel heterozygous c.3034G>T (p.Gly1012Cys) mutation in NPC1, shared by all the siblings. No other point mutations or deletions in NPC1 or NPC2 were found. In four siblings, a diagnosis of late-onset AD was defined according to clinical characterisation and ATN biomarkers (A+, T+, N+) and serum oxysterol analysis showed increased 7-ketocholesterol and cholestane-3 beta,5 alpha,6 beta-triol.Discussion We describe a novel NPC1 heterozygous mutation harboured by different members of a family with autosomal dominant late-onset amnesic AD without NPC-associated features. A missense mutation in homozygous state in the same aminoacidic position has been previously reported in a patient with NPC with severe phenotype. The alteration of serum oxysterols in our family corroborates the pathogenic role of our NPC1 mutation. Our work, illustrating clinical and biochemical disease hallmarks associated with NPC1 heterozygosity in patients affected by AD, provides relevant insights into the pathogenetic mechanisms underlying this possible novel association.
引用
收藏
页码:332 / 339
页数:8
相关论文
共 50 条
  • [1] NPC1 VARIANTS ARE NOT ASSOCIATED WITH PARKINSON'S DISEASE
    Senkevich, K.
    Bencheikh, B. Ouled Amar
    Rudakou, U.
    Yu, E.
    Mufti, K.
    Ruskey, J. A.
    Asayesh, F.
    Laurent, S. B.
    Spiegelman, D.
    Fahn, S.
    Waters, C.
    Monchi, O.
    Dauvilliers, Y.
    Alcalay, R. N.
    Dupre, N.
    Greenbaum, L.
    Hassin-Baer, S.
    Espay, A. J.
    Rouleau, G. A.
    Fon, E. A.
    Gan-Or, Z.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E31 - E31
  • [2] Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer's disease
    Kagedal, Katarina
    Kim, Woojin Scott
    Appelqvist, Hanna
    Chan, Sharon
    Cheng, Danni
    Agholme, Lotta
    Barnham, Kevin
    McCann, Heather
    Halliday, Glenda
    Garner, Brett
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2010, 1801 (08): : 831 - 838
  • [3] Novel compound heterozygous mutation in NPC1 gene cause Niemann–Pick disease type C with juvenile onset
    Maria Cristina Costanzo
    Antonio Gennaro Nicotera
    Mirella Vinci
    Aurelio Vitello
    Agata Fiumara
    Francesco Calì
    Sebastiano Antonino Musumeci
    Journal of Genetics, 2020, 99
  • [4] Neurodegeneration in heterozygous Niemann-Pick type C1 (NPC1) mouse - Implication of heterozygous NPC1 mutations being a risk for tauopathy
    Yu, WX
    Ko, MH
    Yanagisawa, K
    Michikawa, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (29) : 27296 - 27302
  • [5] APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease
    Maulik, Mahua
    Peake, Kyle
    Chung, JiYun
    Wang, Yanlin
    Vance, Jean E.
    Kar, Satyabrata
    HUMAN MOLECULAR GENETICS, 2015, 24 (24) : 7132 - 7150
  • [6] Polymorphisms of NPC1 Gene are Associated with Coronary Heart Disease
    Ma, Weiwei
    Xu, Jing
    Xin, Ying
    Sun, Kai
    Huang, Xiaohong
    Hui, Rutai
    CIRCULATION, 2010, 122 (02) : E101 - E101
  • [7] Novel compound heterozygous mutation in NPC1 gene cause Niemann-Pick disease type C with juvenile onset
    Costanzo, Maria Cristina
    Nicotera, Antonio Gennaro
    Vinci, Mirella
    Vitello, Aurelio
    Fiumara, Agata
    Cali, Francesco
    Musumeci, Sebastiano Antonino
    JOURNAL OF GENETICS, 2020, 99 (01)
  • [8] Identification of heterozygous mutations in the NPC1 and NPC2 genes associated to early onset degenerative dementia in adults
    Cupidi, C.
    Bernardi, L.
    Clodomiro, A.
    Frangipane, F.
    Colao, R.
    Puccio, G.
    Anfossi, M.
    Conidi, M. E.
    Gallo, M.
    Curcio, S. A. M.
    Mirabelli, M.
    Smirne, N.
    Di Lorenzo, R.
    Dardis, A.
    Zampieri, S.
    Maletta, R.
    Bruni, A. C.
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 : S18 - S19
  • [9] Importance of NPC1 Gene 644 A→ G Mutation in Coronary Artery Disease
    Ozturk, Sibel Demir
    Celik, Atac
    Nursal, Ayse Feyda
    Tekcan, Akin
    Rustemoglu, Aydin
    Karakus, Nevin
    Yigit, Serbulent
    INTERNATIONAL JOURNAL OF HUMAN GENETICS, 2017, 17 (02) : 51 - 55
  • [10] A Niemann-Pick disease type C patient with compound heterozygous mutations in NPC1
    Varma, Hemant
    Patel, Chiraag
    Iglesias, Alejandro
    Nagy, Peter
    Mansukhani, Mahesh
    Goldman, James
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2015, 74 (06): : 598 - 598